Asterias Biotherapeutics, Inc. — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$4.0M

Net Income/Loss (FY2017)

-$28.4M

Total Assets (FY2017)

$43.1M

Total Equity (FY2017)

$33.5M

Cash Flows from Operating Activities (FY2017)

-$24.4M

Source: Asterias Biotherapeutics, Inc. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.